322 related articles for article (PubMed ID: 28870692)
21. MC1R germline variants confer risk for BRAF-mutant melanoma.
Landi MT; Bauer J; Pfeiffer RM; Elder DE; Hulley B; Minghetti P; Calista D; Kanetsky PA; Pinkel D; Bastian BC
Science; 2006 Jul; 313(5786):521-2. PubMed ID: 16809487
[TBL] [Abstract][Full Text] [Related]
22. Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Niu HT; Zhou QM; Wang F; Shao Q; Guan YX; Wen XZ; Chen LZ; Feng QS; Li W; Zeng YX; Zhang XS
Pigment Cell Melanoma Res; 2013 Sep; 26(5):646-53. PubMed ID: 23751074
[TBL] [Abstract][Full Text] [Related]
23. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
Søndergaard K
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
[TBL] [Abstract][Full Text] [Related]
24. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
[TBL] [Abstract][Full Text] [Related]
25. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
26. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
[TBL] [Abstract][Full Text] [Related]
27. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
Kuchelmeister C; Schaumburg-Lever G; Garbe C
Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
[TBL] [Abstract][Full Text] [Related]
28. Is there more than one road to melanoma?
Rivers JK
Lancet; 2004 Feb; 363(9410):728-30. PubMed ID: 15005091
[TBL] [Abstract][Full Text] [Related]
29. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
30. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
Shi K; Zhang B; Kong BY; Zhang Y; Igartua C; Mohan LS; Quan VL; Panah E; Isales MC; Beaubier N; Taxter TJ; White KP; Zou L; Gerami P
J Am Acad Dermatol; 2023 May; 88(5):1051-1059. PubMed ID: 31306728
[TBL] [Abstract][Full Text] [Related]
31. Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi.
Park E; Yang S; Emley A; DeCarlo K; Richards J; Mahalingam M
Am J Dermatopathol; 2012 Feb; 34(1):41-6. PubMed ID: 22094233
[TBL] [Abstract][Full Text] [Related]
32. A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress.
Jung HJ; Kweon SS; Lee JB; Lee SC; Yun SJ
JAMA Dermatol; 2013 Nov; 149(11):1281-8. PubMed ID: 24067997
[TBL] [Abstract][Full Text] [Related]
33. Multiple primary acral melanomas in two young caucasian patients.
Lacruz G; Cárdenas I; Carrera C; Díaz A; Puig-Butillè JA; Badenas C; Malvehy J; Puig S
Dermatology; 2014; 228(4):307-10. PubMed ID: 24942556
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions.
Rothrock AT; Torres-Cabala CA; Milton DR; Cho WC; Nagarajan P; Vanderbeck K; Curry JL; Ivan D; Prieto VG; Aung PP
J Cutan Pathol; 2022 Oct; 49(10):859-867. PubMed ID: 35794643
[TBL] [Abstract][Full Text] [Related]
35. Classifying melanocytic tumors based on DNA copy number changes.
Bastian BC; Olshen AB; LeBoit PE; Pinkel D
Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
[TBL] [Abstract][Full Text] [Related]
36. Acral lentiginous melanoma.
Piliang MP
Clin Lab Med; 2011 Jun; 31(2):281-8. PubMed ID: 21549241
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype.
Cress RD; Holly EA; Ahn DK; LeBoit PE; Sagebiel RW
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):831-6. PubMed ID: 8634653
[TBL] [Abstract][Full Text] [Related]
38. Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi.
Eshiba S; Namiki T; Mohri Y; Aida T; Serizawa N; Shibata T; Morinaga H; Nanba D; Hiraoka Y; Tanaka K; Miura K; Tanaka M; Uhara H; Yokozeki H; Saida T; Nishimura EK
Cell Rep; 2021 Aug; 36(5):109492. PubMed ID: 34348144
[TBL] [Abstract][Full Text] [Related]
39. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]